Literature DB >> 8780378

In vivo modeling of HIV-1 mediated neurodegeneration.

E Masliah1.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8780378      PMCID： PMC1865161     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  64 in total

1.  Human immunodeficiency virus type 1 infection of neural xenografts.

Authors:  T A Cvetkovich; E Lazar; B M Blumberg; Y Saito; T A Eskin; R Reichman; D A Baram; C del Cerro; H E Gendelman; M del Cerro
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Cytokine expression in the brain during the acquired immunodeficiency syndrome.

Authors:  W R Tyor; J D Glass; J W Griffin; P S Becker; J C McArthur; L Bezman; D E Griffin
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

Review 3.  Cellular neuropathology in HIV encephalitis.

Authors:  E Masliah; C L Achim; N Ge; R De Teresa; C A Wiley
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1994

Review 4.  Understanding the AIDS dementia complex (ADC). The challenge of HIV and its effects on the central nervous system.

Authors:  R W Price
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1994

5.  Human immunodeficiency virus encephalitis in SCID mice.

Authors:  Y Persidsky; J Limoges; R McComb; P Bock; T Baldwin; W Tyor; A Patil; H S Nottet; L Epstein; H Gelbard; E Flanagan; J Reinhard; S J Pirruccello; H E Gendelman
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

6.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.

Authors:  I L Campbell; C R Abraham; E Masliah; P Kemper; J D Inglis; M B Oldstone; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

7.  Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

Authors:  J C McArthur; D R Hoover; H Bacellar; E N Miller; B A Cohen; J T Becker; N M Graham; J H McArthur; O A Selnes; L P Jacobson
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

8.  Clinical-neuropathologic correlation in HIV-associated dementia.

Authors:  J D Glass; S L Wesselingh; O A Selnes; J C McArthur
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

9.  Cortical dendritic pathology in human immunodeficiency virus encephalitis.

Authors:  E Masliah; N Ge; M Morey; R DeTeresa; R D Terry; C A Wiley
Journal:  Lab Invest       Date:  1992-03       Impact factor: 5.662

10.  Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome.

Authors:  C A Wiley; C Achim
Journal:  Ann Neurol       Date:  1994-10       Impact factor: 10.422
View more
  5 in total

1.  Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration.

Authors:  Jianuo Liu; Nan Gong; Xiuyan Huang; Ashley D Reynolds; R Lee Mosley; Howard E Gendelman
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

Review 2.  Fractalkine (CX3CL1) and brain inflammation: Implications for HIV-1-associated dementia.

Authors:  R Cotter; C Williams; L Ryan; David Erichsen; A Lopez; H Peng; J Zheng
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 3.  The shifting patterns of HIV encephalitis neuropathology.

Authors:  I P Everall; L A Hansen; E Masliah
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

Review 4.  Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS.

Authors:  Mark J Ferris; Charles F Mactutus; Rosemarie M Booze
Journal:  Neurosci Biobehav Rev       Date:  2008-03-18       Impact factor: 8.989

5.  Neuronal Cell Death and Degeneration through Increased Nitroxidative Stress and Tau Phosphorylation in HIV-1 Transgenic Rats.

Authors:  Young-Eun Cho; Myoung-Hwa Lee; Byoung-Joon Song
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.